edited by S.K. Carter, Hamao Umezawa, John Douros, Yoshio Sakurai.
Berlin, Heidelberg
Springer Berlin Heidelberg
1978
(viii, 303 pages)
Recent Results in Cancer Research / Fortschritte der Krebsforschung / Progrès dans les recherches sur le cancer, 63.
1. Summary of Clinical Data on Antitumor Antibiotics in Japan --;2. Role of Antitumor Antibiotics in Current Oncologic Practice --;3. Historical Overview of the National Cancer Institute Fermentation Program --;4. National Cancer Institute's Fermentation Development Program --;5. In Vivo Antitumor Evaluation of Antibiotics. Selected Results from the Drug Evaluation Program of the National Cancer Institute, U.S.A. --;6. Antitumor Antibiotic Bioactivation, Biotransformation, and Derivatization by Microbial Systems --;7. Detection and Assay of Antitumor Antibiotics --;8. Fingerprint Methods Used to Identify Known Antineoplastic Agents in Culture Filtrates --;9. Microbial Process Translation --;Laboratory to Pilot Plant at the Frederick Cancer Research Center --;10. Criteria for Selection of New Analogs of Antitumor Antibiotics --;11. Preclinical Status of Macromomycin at the National Cancer Institute --;12. New Microbial Secondary Metabolites Under Preclinical Development for Cancer Treatment --;13. The Current Status of Chemotherapy for Gastric Cancer in Japan with Special Emphasis on Mitomycin C --;14. Mitomycin C: Experience in the United States, With Emphasis on Gastric Cancer --;15. A Review of the Bleomycin Experience in the United States --;16. Combined Use of Bleomycin with Radiation in the Treatment of Cancer --;17. A Sequential Combination of Bleomycin and Mitomycin C in the Treatment of Advanced Squamous Cancers --;18. Fundamental and Clinical Studies on New Bleomycin Analogs --;19. Experimental Results with the Combination of Bleomycin Plus Mitomycin C --;20. Studies on the Clinical Pharmacology of Bleomycin --;21. Adriamycin and Other Anthracycline Antibiotics Under Study in the United States --;22. Clinical Experiences With Aclacinomycin --;A --;23. Clinical Aspects of Adriamycin in Japan --;24. Clinical Investigations of Neocarzinostatin in Japan --;25. Neocarzinostatin: Initial Clinical and Pharmacologic Studies in the United States --;26. Synthetic Analogs of Antitumor Drugs Under Development in Japan --;27. New Anticancer Antibiotics Under Development and Clinical Evaluation in the National Cancer Institute --;28. Clinical Evaluation of New Antitumor Antibiotics --;29. Antitumor Antibiotics --;Thoughts for the Future.
With contributions by numerous experts
With contributions by numerous experts
Medicine.
Pharmacy.
RC271
.
A65
E358
1978
edited by S.K. Carter, Hamao Umezawa, John Douros, Yoshio Sakurai.